Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-28
2011-12-27
Saeed, Kamal (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C544S105000, C546S234000
Reexamination Certificate
active
08084450
ABSTRACT:
3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4-substituted piperidine compound, a method for the manufacture of a 3,4-substituted piperidine compound, and novel intermediates and partial steps for their synthesis are disclosed. The 3,4-disubstituted piperidine compounds have the formula I,
REFERENCES:
patent: 5721251 (1998-02-01), Chen et al.
patent: 6150526 (2000-11-01), Binggeli et al.
patent: 6197959 (2001-03-01), Breu et al.
patent: 2002/0087002 (2002-07-01), Breu et al.
patent: 2004/0204455 (2004-10-01), Cody et al.
patent: 9513069 (1995-05-01), None
patent: 97/09311 (1997-03-01), None
patent: 0020390 (2000-04-01), None
patent: 0063173 (2000-10-01), None
patent: 00/64887 (2000-11-01), None
patent: 0064873 (2000-11-01), None
patent: 02076440 (2002-10-01), None
patent: 02088101 (2002-11-01), None
patent: 03093267 (2003-11-01), None
patent: 2004058727 (2004-07-01), None
patent: 2004089903 (2004-10-01), None
patent: 2004089915 (2004-10-01), None
patent: 2004096116 (2004-11-01), None
patent: 2004096366 (2004-11-01), None
patent: 2004096769 (2004-11-01), None
patent: 2004096799 (2004-11-01), None
patent: 2004096803 (2004-11-01), None
patent: 2004096804 (2004-11-01), None
patent: 2005/051911 (2005-06-01), None
patent: 2005061457 (2005-07-01), None
patent: 2006/005741 (2006-01-01), None
patent: 2006/066896 (2006-06-01), None
patent: 2006069788 (2006-07-01), None
Marki, “Piperidine Renin” IL FARMACO, vol. 56, No. 1-2, 2001, pp. 21-27.
Maibaum, et al., “Renin inhibitors as novel treatment for cardiovascular diseases” Expert Opinion on Therapeutic Patents. vol. 13, No. 5, 2003, pp. 589-603.
Database Caplus (online) Chemical abstracts Service, Columbus, OH, XP002372913, Database Accession No. 2002:849607 abstract, 2002.
Ujjainwalla, Feroze et al. “Design and Synthesis of Melanocortin Subtype-4 Receptor Agonists: Evolution of the Pyridazinone Archetype” biorg. Med. Chem. Lett. vol. 13, 2003, pp. 4431-4435.
Database Caplus (online) Chemical Abstracts Service Columbus, OH, XP002372914 Database accession No. 1995:951172 abstract, 1995.
Dissertation von Edgar Specker, D-Munster, De Novo Design und Synthese neuer Leitstrukturen als Ueergangszustandsmime tika sur selektiven inhibition der HIV-1 Protease und Cathepsi D: nur p-substituierte verbindungen, 2004.
Breitenstein Werner
Ehara Takeru
Ehrhardt Claus
Grosche Philipp
Hitomi Yuko
Bianchi Kristin
Cross Sophie Binet
Novartis AG
Saeed Kamal
LandOfFree
Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4304856